Search research articles
Contact Us
Filters
Showing results (1-10 of 215) with videos related to
Page
of 22
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 15, 2017
Radiologically isolated syndrome should be treated with disease-modifying therapy - Commentary
Christine Lebrun
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 17, 2025
The confavreux lecture: The radiologically isolated syndrome diagnosis, prognosis and perspectives
Christine Lebrun-Frenay
Revue Neurologique
|
April 2, 2026
Evolving MS diagnostic criteria: Progress and challenges
Christine Lebrun-Frenay
JAMA Neurology
|
July 16, 2014
Moving to fingolimod from natalizumab in multiple sclerosis-reply
Mikael Cohen, Christine Lebrun
CNS Drugs
|
August 26, 2018
Cancer Risk in Patients with Multiple Sclerosis: Potential Impact of Disease-Modifying Drugs
Christine Lebrun, Fanny Rocher
Multiple Sclerosis and Related Disorders
|
June 5, 2019
Immunization and multiple sclerosis: Recommendations from the French multiple sclerosis society
Christine Lebrun, Sandra Vukusic,
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 27, 2012
Treat patients with radiologically isolated syndrome when the MRI brain scan shows dissemination in time: yes
David Brassat, Christine Lebrun-Frenay,
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 29, 2021
MRI findings in blinded trials should be available to treating physicians - Yes
Sandra Vukusic, Christine Lebrun-Frenay
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
September 1, 2023
Letter to the editor on "new algorithmic approach for easier and faster extended disability status scale calculation"
Mikael Cohen, Christine Lebrun Frenay
Continuum (Minneapolis, Minn.)
|
April 2, 2026
Diagnosis of Multiple Sclerosis
Georgina Arrambide, Christine Lebrun-Frénay
Page
of 22
Search research articles
Search
Showing results (1-10 of 215) with videos related to
Sort By:
Page
of 22
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 15, 2017
Radiologically isolated syndrome should be treated with disease-modifying therapy - Commentary
Christine Lebrun
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 17, 2025
The confavreux lecture: The radiologically isolated syndrome diagnosis, prognosis and perspectives
Christine Lebrun-Frenay
Revue Neurologique
|
April 2, 2026
Evolving MS diagnostic criteria: Progress and challenges
Christine Lebrun-Frenay
JAMA Neurology
|
July 16, 2014
Moving to fingolimod from natalizumab in multiple sclerosis-reply
Mikael Cohen, Christine Lebrun
CNS Drugs
|
August 26, 2018
Cancer Risk in Patients with Multiple Sclerosis: Potential Impact of Disease-Modifying Drugs
Christine Lebrun, Fanny Rocher
Multiple Sclerosis and Related Disorders
|
June 5, 2019
Immunization and multiple sclerosis: Recommendations from the French multiple sclerosis society
Christine Lebrun, Sandra Vukusic,
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 27, 2012
Treat patients with radiologically isolated syndrome when the MRI brain scan shows dissemination in time: yes
David Brassat, Christine Lebrun-Frenay,
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 29, 2021
MRI findings in blinded trials should be available to treating physicians - Yes
Sandra Vukusic, Christine Lebrun-Frenay
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
September 1, 2023
Letter to the editor on "new algorithmic approach for easier and faster extended disability status scale calculation"
Mikael Cohen, Christine Lebrun Frenay
Continuum (Minneapolis, Minn.)
|
April 2, 2026
Diagnosis of Multiple Sclerosis
Georgina Arrambide, Christine Lebrun-Frénay
Page
of 22